Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7151280 | 1.00 | CYP3A4 (0.30) | CYP3A4MAPTCYP2C9CYP2C19HSD17B10 | |
| SCHEMBL8528774 | 1.00 | CYP3A4 (0.30) | CYP3A4MAPTCYP2C9CYP2C19HSD17B10 | |
| SCHEMBL5457345 | 1.00 | CYP3A4 (0.30) | CYP3A4MAPTCYP2C9CYP2C19HSD17B10 | |
| SCHEMBL29944830 | 0.84 | — | — | |
| SCHEMBL22748759 | 0.84 | — | — | |
| SCHEMBL182612 | 0.84 | — | — | |
| SCHEMBL7151615 | 0.84 | — | — | |
| SCHEMBL30437675 | 0.84 | — | — | |
| SCHEMBL7147900 | 0.84 | — | — | |
| SCHEMBL29389821 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11312986-B2 | Biosynthesis of everninomicin analogs in Micromonospora carbonacea var aurantiaca | VANDERBILT UNIVERSITY (US) | 2022-04-26 | — | — | US | disclosed |
| EP-3387133-B1 | BIOSYNTHESIS OF EVERNINOMICIN ANALOGS IN MICROMONOSPORA CARBONACEA VAR AURANTIACA | UNIV VANDERBILT (US) | 2021-11-17 | — | — | EP | disclosed |
| US-20200392553-A1 | BIOSYNTHESIS OF EVERNINOMICIN ANALOGS IN MICROMONOSPORA CARBONACEA VAR AURANTIACA | VANDERBILT UNIVERSITY | 2020-12-17 | — | — | US | disclosed |
| US-10696996-B2 | Biosynthesis of everninomicin analogs in Micromonospora carbonacea var aurantiaca | VANDERBILT UNIVERISTY (US) | 2020-06-30 | — | — | US | disclosed |
| US-20190093141-A1 | BIOSYNTHESIS OF EVERNINOMICIN ANALOGS IN MICROMONOSPORA CARBONACEA VAR AURANTIACA | VANDERBILT UNIVERSITY | 2019-03-28 | — | — | US | disclosed |
| EP-3387133-A1 | BIOSYNTHESIS OF EVERNINOMICIN ANALOGS IN MICROMONOSPORA CARBONACEA VAR AURANTIACA | Vanderbilt University (US) | 2018-10-17 | — | — | EP | disclosed |
| WO-2017100650-A1 | BIOSYNTHESIS OF EVERNINOMICIN ANALOGS IN MICROMONOSPORA CARBONACEA VAR AURANTIACA | VANDERBILT UNIVERSITY (US) | 2017-06-15 | — | — | WO | disclosed |
| US-20040006026-A1 | Avilamycin derivatives | COMBINATURE BIOPHARM AG (DE) | 2004-01-08 | — | — | US | disclosed |
| US-6562514-B1 | Stabilized vanadium electrolyte solutions for all-vanadium redox cells and batteries | PINNACLE VRB LIMITED (AU) | 2003-05-13 | — | — | US | disclosed |
| US-6468688-B2 | CHARGING, DISCHARGING EFFICIENCY; VANADIUM ELECTROLYTE | PINNACLE VRB LIMITED (AU) | 2002-10-22 | — | — | US | disclosed |
| US-20010028977-A1 | Charging, discharging efficiency; vanadium electrolyte | JD HOLDING INC. (KY) | 2001-10-11 | — | — | US | disclosed |
| US-6143443-A | ALL-VANADIUM REDOX BATTERY, COMPRISING THE STABILIZED ELECTROLYTE | PINNACLE ARB LIMITED (AU) | 2000-11-07 | — | — | US | disclosed |
| EP-0829104-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1998-03-18 | — | — | EP | disclosed |
| EP-0729648-A4 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LTD (AU) | 1997-01-02 | — | — | EP | disclosed |
| EP-0729648-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-09-04 | — | — | EP | disclosed |
| WO-1995012219-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1995-05-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040006026-A1 | Avilamycin derivatives | AMPD3, AMPD2, ADA | CYP3A4 682/4885MAPT 3599/4885CYP2C9 1907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.